Clinical Trial Update: Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia [Phase 2]

View source ↗

Summary

Phase 2 study results for intranasal PH94B in managing symptoms of Social Anxiety Disorder (generalized social phobia) have been completed, according to the tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Social Anxiety Disorder

Drugs mentioned

• PH94B

Snippet

Sponsor: Pherin Pharmaceuticals, Inc. | Conditions: Social Phobia, Social Anxiety Disorder | Phase 2 | Status: COMPLETED